{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:25:41Z","timestamp":1777051541230,"version":"3.51.4"},"reference-count":9,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CanLivJ"],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:p> BACKGROUND: This report describes a unique case of long-term survival of a young girl who was diagnosed with severe, rapidly progressive lysosomal acid lipase deficiency (LAL-D; historically \u201cWolman disease\u201d) at three months of age and began receiving therapeutic interventions at four months of age. This disease involves rapidly progressive multisystemic impairments and limited survival (6\u201312 months) without treatment. METHODS: Case report taking into account clinical aspects and patient management including a semi-structured interview with the main family caregiver. RESULTS: Presentation at two months of age: severe malnutrition and chronic diarrhea; hypoalbuminemia; low iron, vitamin A, and vitamin D levels; high triglyceride levels; profound anemia; thrombocytopenia; adrenal calcifications; and mild hepatosplenomegaly. Enzyme replacement therapy (ERT) with sebelipase alfa, parenteral nutrition, and a low-fat diet began at age four months. The patient has received sebelipase alfa for &gt;5 years with good tolerability and is thriving, with a body mass index of 16.35 kg\/m<jats:sup>2<\/jats:sup> (80th percentile) despite a stature delay (height &lt;3rd percentile), and mild developmental delay. Optimal medical management requires that family caregivers and health professionals have the knowledge and skills to provide appropriate care and supports multidisciplinary teams through transfer of knowledge to all stakeholders. Effective coordination of services and activities related to child health and development, including navigation of administrative and financial barriers, is also imperative. CONCLUSIONS: Formerly fatal in untreated infants, severe LAL-D, when diagnosed early, can be promptly and effectively treated by combining sebelipase alfa ERT, modified diet, involvement of family caregivers, and multidisciplinary team collaboration. <\/jats:p>","DOI":"10.3138\/canlivj-2021-0041","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T17:59:58Z","timestamp":1654279198000},"page":"428-434","source":"Crossref","is-referenced-by-count":3,"title":["Early diagnosis and successful long-term management of a rare, severe lysosomal acid lipase deficiency\/Wolman disease patient: Infancy to age five"],"prefix":"10.3138","volume":"5","author":[{"given":"Antoine","family":"Cossette","sequence":"first","affiliation":[{"name":"ULaval, Faculty of Medicine, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Castilloux","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology Division, Department of Pediatrics, CHU de Qu\u00e9bec \u2013 ULaval, Faculty of Medicine, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Bouffard","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, CHUS Research Center, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Laflamme","sequence":"additional","affiliation":[{"name":"Pediatric Palliative Care Division, Department of Pediatrics, CHU de Qu\u00e9bec \u2013 ULaval, Faculty of Medicine, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Faure","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Sainte-Justine Hospital, Montr\u00e9al, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Benlamlih","sequence":"additional","affiliation":[{"name":"ULaval, Faculty of Medicine, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Abel","sequence":"additional","affiliation":[{"name":"Alexion Pharmaceuticals, Inc, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Beecroft","sequence":"additional","affiliation":[{"name":"Alexion Pharmaceuticals, Inc, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Francis","sequence":"additional","affiliation":[{"name":"Alexion Pharmaceuticals, Inc, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gen","family":"Drouin","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics, CHU de Qu\u00e9bec \u2013 ULaval, and Research Center of the CHU de Qu\u00e9bec \u2013 ULaval, Faculty of Medicine, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"key":"r1","volume-title":"The online metabolic and molecular bases of inherited disease","author":"Grabowski GA","year":"2019"},{"key":"r2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","volume":"235","author":"Reiner Z","year":"2014","journal-title":"Atherosclerosis"},{"key":"r3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/gim.2015.108","volume":"18","author":"Jones SA","year":"2016","journal-title":"Genet Med"},{"key":"r4","unstructured":"4. Kanuma\u00ae (sebelipase alfa) [package insert]. Boston, MA: Alexion Pharmaceuticals Inc, November 2021."},{"key":"r5","volume-title":"Research design: Qualitative, quantitative, and mixed methods approaches","author":"Creswell JW","year":"2017"},{"key":"r6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jcu.22481","volume":"46","author":"Blitz MJ","year":"2018","journal-title":"J Clin Ultrasound"},{"key":"r7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13023-019-1129-y","volume":"14","author":"Cohen JL","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"r8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13023-021-02134-3","volume":"16","author":"Demaret T","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"r9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.31688\/ABMU.2019.54.1.23","volume":"54","author":"Hanganu B","year":"2019","journal-title":"Arch Balk Med Union"}],"container-title":["Canadian Liver Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/canlivj.utpjournals.press\/doi\/pdf\/10.3138\/canlivj-2021-0041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T17:26:37Z","timestamp":1660757197000},"score":1,"resource":{"primary":{"URL":"https:\/\/canlivj.utpjournals.press\/doi\/10.3138\/canlivj-2021-0041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8,1]]}},"alternative-id":["10.3138\/canlivj-2021-0041"],"URL":"https:\/\/doi.org\/10.3138\/canlivj-2021-0041","relation":{},"ISSN":["2561-4444","2561-4444"],"issn-type":[{"value":"2561-4444","type":"print"},{"value":"2561-4444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}